• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性出血性毛细血管扩张症中报告的心脏表型强调了心律失常、贫血及其治疗带来的负担,但提示心肌梗死发生率降低。

Reported cardiac phenotypes in hereditary hemorrhagic telangiectasia emphasize burdens from arrhythmias, anemia and its treatments, but suggest reduced rates of myocardial infarction.

作者信息

Shovlin C L, Awan I, Cahilog Z, Abdulla F N, Guttmacher A E

机构信息

NHLI Cardiovascular Sciences, Imperial College London, UK; HHTIC London, Respiratory Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.

NHLI Cardiovascular Sciences, Imperial College London, UK; Imperial College School of Medicine, London, UK.

出版信息

Int J Cardiol. 2016 Jul 15;215:179-85. doi: 10.1016/j.ijcard.2016.04.006. Epub 2016 Apr 7.

DOI:10.1016/j.ijcard.2016.04.006
PMID:27116331
Abstract

INTRODUCTION

Cardiac phenotypes should be pronounced in hereditary hemorrhagic telangiectasia (HHT) due to frequent systemic arteriovenous malformations (AVMs), iron deficiency anemia, hypoxemia, hyperdynamic circulations, venous thromboemboli, and paradoxical emboli through pulmonary AVMs.

METHODS/RESULTS: In an international survey, 1025 respondents (median age 55years) met HHT diagnostic criteria: 942 (91.9%) reported nosebleeds, 452 (44.1%) at least daily. AVMs were commonly reported in pulmonary (544, 53%), hepatic (194, 18.9%) and/or cerebral (92, 9.0%) circulations. 770/1025 (75%) had used iron tablets, 256 (25.0%) intravenous iron, and 374 (36.5%) received blood transfusions. Arrhythmias were reported by 113/1025 (11%, including 44 (4.3%) with atrial fibrillation), angina by 36 (3.5%), and cardiac failure by 26 (2.5%). In multivariate logistic regression, these phenotypes were associated with hepatic AVMs/pulmonary hypertension (relatively interchangeable variables), blood transfusions, and intravenous iron. Cardiac insufficiency/failure often provokes intensive anemia treatments, but associations with arrhythmias, particularly with a greater transfusion burden, were less easy to explain. Myocardial infarction (23/1025; 2.2%), and abnormal coronary angiogram (≤31/76, ≤54%) rates appeared low. Provocative preliminary data were obtained including HHT-affected respondents' parents and grandparents in whom HHT could be confidently assigned, or excluded based on autosomal dominant inheritance patterns: in crude and survival analyses, myocardial infarctions were reported less frequently for individuals with HHT, particularly for males (p=0.001).

CONCLUSION

Arrhythmias are the most common cardiac phenotype in HHT, and likely to be aggravated by iron deficiency anemia, its treatments, and/or high output states due to AVMs. Myocardial infarction rates may be reduced in this apparently high risk population.

摘要

引言

由于遗传性出血性毛细血管扩张症(HHT)常伴有全身性动静脉畸形(AVM)、缺铁性贫血、低氧血症、高动力循环、静脉血栓栓塞以及通过肺动静脉畸形导致的反常栓塞,心脏表型应较为明显。

方法/结果:在一项国际调查中,1025名受访者(中位年龄55岁)符合HHT诊断标准:942人(91.9%)报告有鼻出血,其中452人(44.1%)至少每天发生一次。常见的动静脉畸形部位包括肺循环(544例,53%)、肝循环(194例,18.9%)和/或脑循环(92例,9.0%)。770/1025(75%)曾服用铁剂,256人(25.0%)接受过静脉补铁,374人(36.5%)接受过输血。113/1025(11%)报告有心律失常(包括44例(4.3%)房颤),36人(3.5%)报告有胸痛,26人(2.5%)报告有心力衰竭。在多因素逻辑回归分析中,这些表型与肝动静脉畸形/肺动脉高压(相对可互换的变量)、输血和静脉补铁有关。心脏功能不全/心力衰竭常促使强化贫血治疗,但与心律失常的关联,尤其是输血负担较重时的关联,较难解释。心肌梗死发生率(23/1025;2.2%)和冠状动脉造影异常率(≤31/76,≤54%)似乎较低。获得了一些有启发性的初步数据,包括受HHT影响的受访者的父母和祖父母,根据常染色体显性遗传模式可明确诊断或排除HHT:在粗略分析和生存分析中,HHT患者发生心肌梗死的频率较低,尤其是男性(p=0.001)。

结论

心律失常是HHT最常见的心脏表型,可能因缺铁性贫血、其治疗方法和/或动静脉畸形导致的高输出状态而加重。在这个明显的高风险人群中,心肌梗死发生率可能降低。

相似文献

1
Reported cardiac phenotypes in hereditary hemorrhagic telangiectasia emphasize burdens from arrhythmias, anemia and its treatments, but suggest reduced rates of myocardial infarction.遗传性出血性毛细血管扩张症中报告的心脏表型强调了心律失常、贫血及其治疗带来的负担,但提示心肌梗死发生率降低。
Int J Cardiol. 2016 Jul 15;215:179-85. doi: 10.1016/j.ijcard.2016.04.006. Epub 2016 Apr 7.
2
Injections of Intravenous Contrast for Computerized Tomography Scans Precipitate Migraines in Hereditary Hemorrhagic Telangiectasia Subjects at Risk of Paradoxical Emboli: Implications for Right-to-Left Shunt Risks.用于计算机断层扫描的静脉注射造影剂会诱发有反常栓塞风险的遗传性出血性毛细血管扩张症患者偏头痛:对右向左分流风险的影响。
Headache. 2016 Nov;56(10):1659-1663. doi: 10.1111/head.12963. Epub 2016 Oct 11.
3
[Bevacizumab: a new success in hereditary hemorrhagic telangiectasia].[贝伐单抗:遗传性出血性毛细血管扩张症治疗的新突破]
Rev Med Interne. 2015 Sep;36(9):623-5. doi: 10.1016/j.revmed.2014.11.004. Epub 2015 Jan 13.
4
Iron deficiency anemia related to hereditary hemorrhagic telangiectasia: response to treatment with bevacizumab.遗传性出血性毛细血管扩张症相关缺铁性贫血:贝伐珠单抗治疗的反应。
Am J Med Sci. 2012 Mar;343(3):249-51. doi: 10.1097/MAJ.0b013e3182429866.
5
Circulatory contributors to the phenotype in hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症中表型的循环因素
Front Genet. 2015 Apr 9;6:101. doi: 10.3389/fgene.2015.00101. eCollection 2015.
6
Relationships between epistaxis, migraines, and triggers in hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症中鼻出血、偏头痛与诱发因素之间的关系。
Laryngoscope. 2014 Jul;124(7):1521-8. doi: 10.1002/lary.24526. Epub 2014 Jan 23.
7
Pulmonary hypertension and hepatic encephalopathy: lethal complications of Rendu-Osler-Weber disease.肺动脉高压与肝性脑病:遗传性出血性毛细血管扩张症的致命并发症。
J R Coll Physicians Edinb. 2014;44(2):126-9. doi: 10.4997/JRCPE.2014.207.
8
Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症中脑血管畸形的出血风险
J Neurosurg. 2000 May;92(5):779-84. doi: 10.3171/jns.2000.92.5.0779.
9
Angina pectoris or myocardial infarctions, pulmonary arteriovenous malformations, hereditary hemorrhagic telangiectasia, and paradoxical emboli.心绞痛或心肌梗死、肺动静脉畸形、遗传性出血性毛细血管扩张症和矛盾栓塞。
Am J Cardiol. 2013 Sep 1;112(5):731-4. doi: 10.1016/j.amjcard.2013.04.052. Epub 2013 May 21.
10
A case report of acute myocardial infarction with hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症致急性心肌梗死 1 例报告
J Cardiothorac Surg. 2024 Oct 16;19(1):607. doi: 10.1186/s13019-024-03106-x.

引用本文的文献

1
The Complexities of Managing Acute Coronary Syndrome in a Patient With Hereditary Hemorrhagic Telangiectasia: A Case Report and Literature Review.遗传性出血性毛细血管扩张症患者急性冠状动脉综合征的管理复杂性:病例报告及文献综述
Cureus. 2025 Mar 18;17(3):e80758. doi: 10.7759/cureus.80758. eCollection 2025 Mar.
2
Hereditary haemorrhagic telangiectasia.遗传性出血性毛细血管扩张症
Nat Rev Dis Primers. 2025 Jan 9;11(1):1. doi: 10.1038/s41572-024-00585-z.
3
Mutations causing premature termination codons discriminate and generate cellular and clinical variability in HHT.
导致提前终止密码子的突变可区分并产生 HHT 的细胞和临床变异性。
Blood. 2024 May 30;143(22):2314-2331. doi: 10.1182/blood.2023021777.
4
Pathogenic Variant Frequencies in Hereditary Haemorrhagic Telangiectasia Support Clinical Evidence of Protection from Myocardial Infarction.遗传性出血性毛细血管扩张症的致病变异频率支持预防心肌梗死的临床证据。
J Clin Med. 2023 Dec 31;13(1):250. doi: 10.3390/jcm13010250.
5
Incidence and Predictors of Clinically Significant Bleedings after Transcatheter Left Atrial Appendage Closure.经导管左心耳封堵术后临床显著出血的发生率及预测因素。
Int J Environ Res Public Health. 2022 Oct 24;19(21):13802. doi: 10.3390/ijerph192113802.
6
Left Atrial Appendage Occlusion: A Therapeutic Option in a Patient With Atrial Fibrillation and Hereditary Hemorrhagic Telangiectasia.左心耳封堵术:心房颤动合并遗传性出血性毛细血管扩张症患者的一种治疗选择
Cureus. 2021 Jun 1;13(6):e15367. doi: 10.7759/cureus.15367. eCollection 2021 Jun.
7
Myocardial Infarction in a Patient With Hereditary Hemorrhagic Telangiectasia: A Case Report and Review of Literature.遗传性出血性毛细血管扩张症患者的心肌梗死:一例报告并文献复习
Cureus. 2021 May 24;13(5):e15219. doi: 10.7759/cureus.15219.
8
Hereditary Hemorrhagic Telangiectasia (HHT) and Survival: The Importance of Systematic Screening and Treatment in HHT Centers of Excellence.遗传性出血性毛细血管扩张症(HHT)与生存:在卓越的HHT中心进行系统筛查和治疗的重要性。
J Clin Med. 2020 Nov 6;9(11):3581. doi: 10.3390/jcm9113581.
9
Mutational and phenotypic characterization of hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症的突变和表型特征。
Blood. 2020 Oct 22;136(17):1907-1918. doi: 10.1182/blood.2019004560.
10
Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia: Real-World Data from the Gemelli Hospital HHT Registry.遗传性出血性毛细血管扩张症的抗栓治疗:来自杰梅利医院遗传性出血性毛细血管扩张症登记处的真实世界数据。
J Clin Med. 2020 Jun 2;9(6):1699. doi: 10.3390/jcm9061699.